XML 70 R63.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segment Information (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2010
Segment Reporting Information [Line Items]                      
Loss Contingency Accrual , Product Liability, Net, Explanation of Material Change in Accrual                 -17403    
Revenues $ 390,249 $ 355,215 $ 342,707 $ 318,639 $ 377,760 $ 328,283 $ 312,425 $ 188,980 $ 1,406,810 $ 1,207,448 $ 1,257,733
Operating Income (Loss)                 222,316 85,212 203,712
Restructuring Charges (877) 1,164 99 258 779 (23) 105 341 644 1,202 4,848
OperatingSegmentHealthcare [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 1,013,102 835,832 892,474
Operating Income (Loss)                 141,742 21,317 151,520
OperatingSegmentLifeSciences [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 226,658 215,437 218,209
Operating Income (Loss)                 41,633 33,069 30,952
OperatingSegmentIsomedix [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 164,257 152,242 140,871
Operating Income (Loss)                 47,596 39,833 31,103
OperatingSegmentAllExceptCorpandOther [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 1,404,017 1,203,511 1,251,554
Operating Income (Loss)                 230,971 94,219 213,575
OperatingSegmentCorpandOther [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 2,793 3,937 6,179
Operating Income (Loss)                 (8,655) (9,007) (9,863)
OperatingSegmentAll [Member]
                     
Segment Reporting Information [Line Items]                      
Revenues                 1,406,810 1,207,448 1,257,733
Operating Income (Loss)                 222,316 85,212 203,712
Product Rebate Program [Member]
                     
Segment Reporting Information [Line Items]                      
Loss Contingency, Accrual Carrying Value, Current             (110,004)        
Customer Rebates [Member]
                     
Segment Reporting Information [Line Items]                      
Loss Contingency Accrual , Product Liability, Net, Explanation of Material Change in Accrual                 15306    
Loss Contingency, Accrual Carrying Value, Current             (102,313)        
Pending or Threatened Litigation [Member]
                     
Segment Reporting Information [Line Items]                      
Estimated Litigation Liability           19,796          
Life Science Member [Member]
                     
Segment Reporting Information [Line Items]                      
Restructuring Charges                   $ 190 $ 555